Preclinical pharmacology of B-20991, a 5-HT1A receptor agonist with anxiolytic activity
- 1 March 1998
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 344 (2-3) , 127-135
- https://doi.org/10.1016/s0014-2999(97)01583-5
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Der 5-HT1A-Rezeptor: Ein neues Wirkprinzip psychopharmakologischer Therapiestrategien?Fortschritte der Neurologie · Psychiatrie, 1996
- Quantitative autoradiography of the serotonin transporter to assess the distribution of serotonergic projections from the dorsal raphe nucleusSynapse, 1994
- Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics and antidepressantsLife Sciences, 1992
- β-Alanine potentiation of [3H]flunitrazepam binding to rat spinal cord homogenatesNeuroscience Letters, 1990
- 5-HT1A receptor-related anxiolyticsTrends in Pharmacological Sciences, 1987
- [3H]1‐[2‐(4‐Aminophenyl)Ethyl]‐4‐(3‐Trifluoromethylphenyl)Piperazine: A Selective Radioligand for 5‐HT1A Receptors in Rat BrainJournal of Neurochemistry, 1986
- Hypothermia in the rat induced by the potent serotoninergic agent 8-OH-DPATJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Effect of 8-hydroxy-2-(di-n-propylamino) tetralin on rat prolactin secretionJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1984
- 8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activityJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1982
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973